aztreonam has been researched along with Urinary Tract Diseases in 5 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)." | 9.06 | [Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988) |
| "52 patients with serious urinary tract infections were randomised to receive either aztreonam (35) or gentamicin (17)." | 9.05 | Aztreonam compared with gentamicin for treatment of serious urinary tract infections. ( Appelbaum, PC; Lombard, JS; Moyer, JE; Sattler, FR; Schramm, M, 1984) |
| "Aztreonam was administered to 30 patients, ages 0." | 5.27 | Aztreonam in the treatment of severe urinary tract infections in pediatric patients. ( Assael, BM; Boccazzi, A; Colombo, R; Crossignani, RM; Garlaschi, L; Rancilio, L; Rusconi, F, 1986) |
| "Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)." | 5.06 | [Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988) |
| "52 patients with serious urinary tract infections were randomised to receive either aztreonam (35) or gentamicin (17)." | 5.05 | Aztreonam compared with gentamicin for treatment of serious urinary tract infections. ( Appelbaum, PC; Lombard, JS; Moyer, JE; Sattler, FR; Schramm, M, 1984) |
| "Aztreonam was administered to 30 patients, ages 0." | 1.27 | Aztreonam in the treatment of severe urinary tract infections in pediatric patients. ( Assael, BM; Boccazzi, A; Colombo, R; Crossignani, RM; Garlaschi, L; Rancilio, L; Rusconi, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sattler, FR | 1 |
| Moyer, JE | 1 |
| Schramm, M | 1 |
| Lombard, JS | 1 |
| Appelbaum, PC | 1 |
| Giannoni, R | 1 |
| Legramandi, C | 1 |
| Fonte, A | 1 |
| Yoshida, K | 1 |
| Uchijima, Y | 1 |
| Kobayashi, N | 1 |
| Suwata, J | 1 |
| Nakame, Y | 1 |
| Saitoh, H | 1 |
| Negishi, T | 1 |
| Yamada, T | 1 |
| Kageyama, Y | 1 |
| Kura, N | 1 |
| Rusconi, F | 1 |
| Assael, BM | 1 |
| Boccazzi, A | 1 |
| Colombo, R | 1 |
| Crossignani, RM | 1 |
| Garlaschi, L | 1 |
| Rancilio, L | 1 |
| Dalet, F | 1 |
| del Río, G | 1 |
| Rabinad, E | 1 |
2 trials available for aztreonam and Urinary Tract Diseases
| Article | Year |
|---|---|
Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacteria; Clinical Trials as Topic; Femal | 1984 |
[Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Aztreonam; Bacterial Infections; Che | 1988 |
3 other studies available for aztreonam and Urinary Tract Diseases
| Article | Year |
|---|---|
"Short-term" prophylaxis by aztreonam in prevention of post-operative infections in patients undergoing transurethral surgery.
Topics: Aztreonam; Humans; Postoperative Complications; Premedication; Urethra; Urinary Tract Infections; Ur | 1988 |
Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
Topics: Adolescent; Aztreonam; Child; Child, Preschool; Citrobacter; Enterobacter; Enterobacteriaceae Infect | 1986 |
[Aztreonam: prevention of bacteremia in urologic surgery in patients with urinary infection].
Topics: Adult; Aged; Aztreonam; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Postoperative Com | 1988 |